Establishment of normal myofiber size distribution in children and young adults

Area of Science:

• Pediatric Pathology
• Skeletal Muscle Histology
• Diagnostic Standards

Background:

• Myofiber size abnormalities are key indicators in skeletal muscle biopsies, particularly when fibers are small.
• Assessing pediatric myofiber size has been challenging due to limitations in tools for analyzing numerous samples.
• Accurate reference ranges are needed for diagnosing pediatric neuromuscular conditions.

Purpose of the Study:

• To establish normative ranges for myofiber size in children and young adults.
• To provide a standardized dataset for diagnostic and research purposes in pediatric muscle pathology.
• To facilitate the identification of abnormal myofiber sizes in clinical practice.

Main Methods:

• Analysis of 349 normal pediatric skeletal muscle biopsy specimens (4 weeks to 25 years).
• Histological assessment using H&E staining and minFeret diameter measurement via Visiopharm software.
• Grouping data into 18 age cohorts to define sex-specific normal ranges.

Main Results:

• Established normative ranges for myofiber size (minFeret diameter) across 18 pediatric age cohorts.
• Demonstrated the utility of these ranges through a pilot study comparing normal and abnormal cases.
• Provided a user-friendly dataset for diagnostic application.

Conclusions:

• The study successfully established reliable, age- and sex-specific reference ranges for pediatric myofiber size.
• These standards aid in the accurate diagnosis of conditions involving abnormal myofiber dimensions.
• This dataset serves as a valuable tool for pediatric muscle pathology research and clinical evaluation.